Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. From the ones listed this time, here's a few in our areas of research interest:
Gong CL, Hay JW. Cost-effectiveness analysis of abiraterone and sipuleucel-T in asymptomatic metastatic castration-resistant prostate cancer. J Natl Compr Canc Netw. 2014 Oct;12(10):1417-25. PubMed PMID: 25313181.
van Hees F, Zauber AG, Klabunde CN, et. al. The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: a modeling study. JAMA Intern Med. 2014 Oct 1;174(10):1568-76. PubMed PMID: 25133641.
Tran-Duy A, Boonen A, Kievit W, et. al. Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis. Pharmacoeconomics. 2014 Oct;32(10):1015-28. PubMed PMID: 24972589.
Zafari Z, Thorlund K, FitzGerald JM, et. al. Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes. Pharmacoeconomics. 2014 Oct;32(10):995-1004. PubMed PMID: 24920194.
